>
Menu
About
The ACS’s mission-driven venture capital fund
Portfolio
Investing in for-profit companies developing novel cancer-focused treatments
Team
Fighting for a world without cancer
News
Contact
Become a Donor
August 2023
BrightEdge Annual Report 2022
Related Information
BrightEdge Annual Report
View Report
ACS BrightEdge Poised to Help Improve 1.5 Million Lives By Investing in Cancer-Focused Therapies and Technologies
Click the red "View Report" link to read the full report